|
🐢
|
Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
9 auth.
P. McEwan,
O. Darlington,
J. McMurray,
P. Jhund,
K. Docherty,
M. Böhm,
...
M. Petrie,
K. Bergenheim,
Lei Qin
|
6 |
2020 |
6
🐢
|
|
🐜
|
Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK
9 auth.
C. Linde,
Lei Qin,
A. Bakhai,
H. Furuland,
M. Evans,
D. Ayoubkhani,
...
E. Palaka,
H. Bennett,
P. McEwan
|
6 |
2019 |
6
🐜
|
|
🐜
|
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
23 auth.
Yi Li,
Zhenyang Liang,
Lei Qin,
Mian Wang,
Xianzhao Wang,
Huanyi Zhang,
Y. Liu,
Yan Li,
Zhisheng Jia,
Limin Liu,
...
Hongya Zhang,
Jun Luo,
S. Dong,
Jincheng Guo,
Hengqing Zhu,
Sheng-li Li,
Haijun Zheng,
Lijun C Liu,
Yanqing Wu,
Yiming Zhong,
M. Qiu,
Yaling Han,
G. Stone
|
5 |
2022 |
5
🐜
|
|
🐢
|
Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
7 auth.
C. Linde,
A. Bakhai,
H. Furuland,
M. Evans,
P. McEwan,
D. Ayoubkhani,
...
Lei Qin
|
5 |
2019 |
5
🐢
|
|
🐢
|
Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
9 auth.
H. Furuland,
P. McEwan,
M. Evans,
C. Linde,
D. Ayoubkhani,
A. Bakhai,
...
E. Palaka,
H. Bennett,
Lei Qin
|
5 |
2018 |
5
🐢
|
|
🐜
|
Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial.
17 auth.
Bo Xu,
R. Gao,
Yue-jing Yang,
Xue-bin Cao,
Lei Qin,
Yi Li,
Zhan-quan Li,
Xueqi Li,
Hailong Lin,
Yong Guo,
...
Yi-tong Ma,
Jianan Wang,
S. Nie,
Liang Xu,
Eric Cao,
C. Guan,
G. Stone
|
5 |
2016 |
5
🐜
|
|
🦁
|
MicroRNA-497 promotes proliferation and inhibits apoptosis of cardiomyocytes through the downregulation of Mfn2 in a mouse model of myocardial ischemia-reperfusion injury.
7 auth.
Lei Qin,
Wen Yang,
Yao-Xin Wang,
Zhenjun Wang,
Chenchen Li,
Man Li,
...
Jieyun Liu
|
5 |
2018 |
5
🦁
|
|
🦁
|
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study
8 auth.
Lei Qin,
Stephanie Chen,
E. Flood,
A. Shaunik,
B. Romero,
M. de la Cruz,
...
C. Alvarez,
S. Grandy
|
4 |
2017 |
4
🦁
|
